Historical shareholding details of Strategic Advisers U.S. Total Stock holdings in Fulcrum Therapeutics Inc (FULC)

Monthly changes of Strategic Advisers U.S. Total Stock shareholding in Fulcrum Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Jan 31, 2025 Strategic Advisers U.S. Total Stock 39,400 0.07%
Dec 31, 2024 Strategic Advisers U.S. Total Stock 45,364 0.08%
Nov 30, 2024 Strategic Advisers U.S. Total Stock 59,502 0.11%
Oct 31, 2024 Strategic Advisers U.S. Total Stock 59,763 0.11%
Sep 30, 2024 Strategic Advisers U.S. Total Stock 53,900 0.10%
Jul 31, 2024 Strategic Advisers U.S. Total Stock 14,100 0.02%
Jun 30, 2024 Strategic Advisers Large Cap 16,200 0.03%
May 31, 2024 Strategic Advisers Large Cap 16,400 0.03%
Apr 30, 2024 Strategic Advisers Large Cap 14,300 0.02%
Mar 31, 2024 Strategic Advisers Large Cap 15,000 0.02%
Feb 29, 2024 Strategic Advisers Large Cap 15,589 0.03%
Jan 31, 2024 Strategic Advisers Large Cap 14,800 0.02%
Dec 31, 2023 Strategic Advisers Large Cap 12,900 0.02%
Oct 31, 2023 Strategic Advisers® Large Cap 12,949 0.02%
Sep 30, 2023 Strategic Advisers® Large Cap 13,400 0.02%
Jul 31, 2023 Strategic Advisers® Large Cap 11,900 0.02%
Jun 30, 2023 Strategic Advisers® Large Cap 11,600 0.02%
Apr 30, 2023 Strategic Advisers® Large Cap 5,500 0.01%

View all ownership details of Fulcrum Therapeutics Inc